Gulec, U. K. Et Al. 2017. PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.27 , 220.

Gulec, U. K., Bagir, E., Paydas, S., Seydaoglu, G., Guzel, A. B., & Vardar, M. A., (2017). PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.27, 220.

Gulec, ÜMRAN Et Al. "PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER," INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.27, 220, 2017

Gulec, ÜMRAN K. Et Al. "PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER." INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.27, pp.220, 2017

Gulec, U. K. Et Al. (2017) . "PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER." INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.27, p.220.

@article{article, author={ÜMRAN KÜÇÜKGÖZ GÜLEÇ Et Al. }, title={PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER}, journal={INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER}, year=2017, pages={220} }